Caballero-Villarraso J - Search Results

1

Bevacizumab Allows Preservation of Liver Function and its Regenerative Capacity after Major Hepatectomy.

Valverde A, Ciria R, Caballero-Villarraso J, Aguilar-Melero P, Ferrín G, Ranchal I, Linares C, Herencia C, González-Rubio S, de la Mata M, Naranjo Á, Briceño J. Valverde A, et al. Anticancer Agents Med Chem. 2019;19(11):1388-1398. doi: 10.2174/1871520619666190417162409. Anticancer Agents Med Chem. 2019. PMID: 31038079

2

An iron-deficient diet during development induces oxidative stress in relation to age and gender in Wistar rats.

Vieyra-Reyes P, Millán-Aldaco D, Palomero-Rivero M, Jiménez-Garcés C, Hernández-González M, Caballero-Villarraso J. Vieyra-Reyes P, et al. J Physiol Biochem. 2017 Feb;73(1):99-110. doi: 10.1007/s13105-016-0529-x. Epub 2016 Oct 24. J Physiol Biochem. 2017. PMID: 27778230

3

Dose-dependent S-allyl cysteine ameliorates multiple sclerosis disease-related pathology by reducing oxidative stress and biomarkers of dysbiosis in experimental autoimmune encephalomyelitis.

Escribano BM, Luque E, Aguilar-Luque M, Feijóo M, Caballero-Villarraso J, Torres LA, Ramirez V, García-Maceira FI, Agüera E, Santamaria A, Túnez I. Escribano BM, et al. Eur J Pharmacol. 2017 Nov 15;815:266-273. doi: 10.1016/j.ejphar.2017.09.025. Epub 2017 Sep 19. Eur J Pharmacol. 2017. PMID: 28939293

4

Comparative of transcranial magnetic stimulation and other treatments in experimental autoimmune encephalomyelitis.

Medina-Fernandez FJ, Escribano BM, Luque E, Caballero-Villarraso J, Gomez-Chaparro JL, Feijoo M, Garcia-Maceira FI, Pascual-Leone A, Drucker-Colin R, Tunez I. Medina-Fernandez FJ, et al. Brain Res Bull. 2018 Mar;137:140-145. doi: 10.1016/j.brainresbull.2017.11.018. Epub 2017 Dec 1. Brain Res Bull. 2018. PMID: 29198860

5

Extra-Virgin Olive Oil Modifies the Changes Induced in Non-Nervous Organs and Tissues by Experimental Autoimmune Encephalomyelitis Models.

Conde C, Escribano BM, Luque E, Feijóo M, Caballero-Villarraso J, Valdelvira ME, Ochoa-Sepúlveda JJ, Lillo R, Paz E, Santamaría A, Agüera E, Túnez I. Conde C, et al. Nutrients. 2019 Oct 14;11(10):2448. doi: 10.3390/nu11102448. Nutrients. 2019. PMID: 31615022 Free PMC article.

6

Hypoxia preconditioning increases the ability of healthy but not diabetic rat-derived adipose stromal/stem cells (ASC) to improve histological lesions of streptozotocin-induced diabetic nephropathy.

Carmona M, Paco-Meza LM, Ortega R, Cañadillas S, Caballero-Villarraso J, Blanco A, Herrera C. Carmona M, et al. Pathol Res Pract. 2022 Feb;230:153756. doi: 10.1016/j.prp.2021.153756. Epub 2021 Dec 31. Pathol Res Pract. 2022. PMID: 35032832 Free article.

7

Protective effects of melatonin on changes occurring in the experimental autoimmune encephalomyelitis model of multiple sclerosis.

Escribano BM, Muñoz-Jurado A, Caballero-Villarraso J, Valdelvira ME, Giraldo AI, Paz-Rojas E, Gascón F, Santamaría A, Agüera E, Túnez I. Escribano BM, et al. Mult Scler Relat Disord. 2022 Feb;58:103520. doi: 10.1016/j.msard.2022.103520. Epub 2022 Jan 11. Mult Scler Relat Disord. 2022. PMID: 35038645 Free article.

8

Hormone replacement therapy in children with growth hormone deficiency: impact on immune profile.

Caballero-Villarraso J, Aguado R, Cañete MD, Roldán L, Cañete R, Santamaría M. Caballero-Villarraso J, et al. Arch Physiol Biochem. 2021 Jun;127(3):245-249. doi: 10.1080/13813455.2019.1628070. Epub 2019 Jun 19. Arch Physiol Biochem. 2021. PMID: 31215254

9

Postprandial Lipemia Modulates Pancreatic Alpha-Cell Function in the Prediction of Type 2 Diabetes Development: The CORDIOPREV Study.

Pozuelo-Sanchez I, Villasanta-Gonzalez A, Alcala-Diaz JF, Vals-Delgado C, Leon-Acuña A, Gonzalez-Requero A, Yubero-Serrano EM, Luque RM, Caballero-Villarraso J, Quesada I, Ordovas JM, Pérez-Martinez P, Roncero-Ramos I, Lopez-Miranda J. Pozuelo-Sanchez I, et al. J Agric Food Chem. 2020 Feb 5;68(5):1266-1275. doi: 10.1021/acs.jafc.9b06801. Epub 2020 Jan 27. J Agric Food Chem. 2020. PMID: 31937103 Clinical Trial.

10

Lactose and Casein Cause Changes on Biomarkers of Oxidative Damage and Dysbiosis in an Experimental Model of Multiple Sclerosis.

Escribano BM, Muñoz-Jurado A, Luque E, Conde C, Feijóo M, LaTorre M, Valdelvira ME, Buendía P, Giraldo AI, Caballero-Villarraso J, Santamaría A, Agüera E, Túnez I. Escribano BM, et al. CNS Neurol Disord Drug Targets. 2022;21(8):680-692. doi: 10.2174/1871527320666211207101113. CNS Neurol Disord Drug Targets. 2022. PMID: 34875994

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

61 results

Search Page